FOLD

Amicus Therapeutics, Inc. (FOLD) is a pioneering biopharmaceutical firm based in Philadelphia, Pennsylvania, committed to developing innovative therapies for rare metabolic disorders. Utilizing its proprietary enzyme replacement therapy platform, Amicus focuses on creating personalized medicine solutions that cater to previously neglected patient populations. The company boasts a promising pipeline of advanced therapeutics targeting lysosomal storage disorders, solidifying its reputation as a leader in the biotechnology industry dedicated to addressing critical unmet medical needs in rare diseases.